☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
PharmAbcine
PharmAbcine Reports First Patient Dosing with PMC-309 in P-Ia/b Study for Advanced or Metastatic Solid Tumors
January 24, 2024
PharmAbcine Announced the Preclinical Data of PMC-403 for Idiopathic Systemic Capillary Leak Syndrome (ISCLS, a.k.a. Clarkson Dise...
November 23, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.